Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) EBIT (2016 - 2025)

Bio Key International's EBIT history spans 16 years, with the latest figure at -$892190.0 for Q3 2025.

  • For Q3 2025, EBIT fell 53.72% year-over-year to -$892190.0; the TTM value through Sep 2025 reached -$3.9 million, up 28.95%, while the annual FY2024 figure was -$4.0 million, 54.56% up from the prior year.
  • EBIT for Q3 2025 was -$892190.0 at Bio Key International, up from -$1.1 million in the prior quarter.
  • Across five years, EBIT topped out at -$49168.0 in Q2 2021 and bottomed at -$5.0 million in Q4 2022.
  • The 5-year median for EBIT is -$1.1 million (2025), against an average of -$1.5 million.
  • The largest annual shift saw EBIT surged 75.53% in 2021 before it crashed 3088.04% in 2022.
  • A 5-year view of EBIT shows it stood at -$2.0 million in 2021, then tumbled by 149.89% to -$5.0 million in 2022, then soared by 45.48% to -$2.7 million in 2023, then soared by 53.46% to -$1.3 million in 2024, then increased by 29.62% to -$892190.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's EBIT are -$892190.0 (Q3 2025), -$1.1 million (Q2 2025), and -$640638.0 (Q1 2025).